Politics

World

Business

Entertainment

Health

First Oral Therapy for Thalassemia Anemia Approved by US FDA

The US FDA has approved Mitapivat (Aqvesme), the first oral treatment for anemia in adults with alpha or beta thalassemia. This breakthrough could reduce transfusion dependence, offering new hope for high-burden countries like India. Read more.